Stock Research: Smith & Nephew

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Smith & Nephew

LSE:SN. GB0009223206
90
  • Value
    57
  • Growth
    79
  • Safety
    Safety
    77
  • Combined
    94
  • Sentiment
    57
  • 360° View
    360° View
    90
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Smith & Nephew is a medical technology company focused on repairing, regenerating, and replacing soft and hard tissue. It operates in the Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management industries. The company's main regions are not mentioned in the description. In the last fiscal year, the company had a market cap of $12,774 million, profits of $4,079 million, revenue of $5,810 million, and 17,349 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 90 (better than 90% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Smith & Nephew are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Smith & Nephew. The consolidated Value Rank has an attractive rank of 77, which means that the share price of Smith & Nephew is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 77% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 79, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 57. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 57. ...read more

more
Index
FTSE All Shares
FTSE 100
FTSE 350
Dividends Europe
Robotics
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
77 89 89 95
Growth
79 13 47 23
Safety
Safety
57 58 54 34
Sentiment
57 27 61 7
360° View
360° View
90 41 76 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
52 54 62 29
Opinions Change
45 43 46 50
Pro Holdings
n/a 46 66 30
Market Pulse
45 26 40 30
Sentiment
57 27 61 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
77 89 89 95
Growth
79 13 47 23
Safety Safety
57 58 54 34
Combined
94 51 88 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
79 89 84 84
Price vs. Earnings (P/E)
56 62 62 68
Price vs. Book (P/B)
43 63 66 74
Dividend Yield
82 86 84 80
Value
77 89 89 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
30 16 24 33
Profit Growth
75 16 42 35
Capital Growth
73 53 76 67
Stock Returns
75 55 45 9
Growth
79 13 47 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
36 34 38 26
Refinancing
77 78 71 65
Liquidity
47 59 43 39
Safety Safety
57 58 54 34

Similar Stocks

Discover high‑ranked alternatives to Smith & Nephew and broaden your portfolio horizons.

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Vodafone

LSE:VOD
Country: United Kingdom
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Fresenius

XTRA:FRE
Country: Germany
Industry: Health Care Services
Size: X-Large
Full Stock Analysis

Schroders

LSE:SDR
Country: United Kingdom
Industry: Asset Management & Custody
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.